Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2014, Article ID 487364, 4 pages
Case Report

Point of Care Perioperative Coagulation Management in Liver Transplantation and Complete Portal Vein Thrombosis

1Division of Anaesthesia and Resuscitation, Department of Emergency, Ospedali Riuniti, Via Conca 71, 60020 Ancona, Italy
2Department of Emergency, Anesthesia and Resuscitation Unit, Università Politecnica delle Marche, Via Conca 71, 60020 Ancona, Italy
3Department of Liver Surgery and Transplantation, Ospedali Riuniti, Via Conca 71, 60020 Ancona, Italy

Received 26 November 2013; Accepted 24 December 2013; Published 6 February 2014

Academic Editors: C. Costa and S. Faenza

Copyright © 2014 Cristiano Piangatelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Liver transplantation (LT) is a serious hemostatic challenge in patients with portal vein thrombosis (PVT). Advances in monitoring systems have improved surgery in this setting. We report the successful application of a point-of-care (POC) rotational viscoelastic thromboelastometry-guided (TEM) testing system (ROTEM) which allowed management of coagulation during LT in a 64-year-old cirrhotic patient with a model for end-stage liver disease (MELD) score of 16. Perioperatively, the patient showed complete PVT, hepatomegaly, splenomegaly, recanalization of the umbilical vein, and portosystemic shunt. Macroscopic liver and spleen adherences with collateral circulation were evident. Coagulation factors and fibrinolysis were assessed preoperatively and at graft reperfusion to evaluate the need of hemostatic therapy. Based on ROTEM findings, the patient received 16 g of human fibrinogen concentrate, half preoperatively (with prothrombin complex concentrate 2000 IU, tranexamic acid 1 g, and platelets 2 IU), and two doses of 4 g before and after graft reperfusion; we achieved normalization of all monitored parameters. No ischemia-reperfusion syndrome was present. Postoperatively portal vein flux at Color-Doppler ultrasonography was normal. After a 3-day ICU stay, the patient was moved to the Department of Surgery and discharged on day 14. The postoperative course was uneventful and did not require any further haemostatic therapy.